blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2269636

EP2269636 - Chlamydia trachomatis antigens for vaccine and diagnostic use [Right-click to bookmark this link]
StatusThe application has been refused
Status updated on  15.11.2013
Database last updated on 31.08.2024
Most recent event   Tooltip15.11.2013Refusal of applicationpublished on 18.12.2013  [2013/51]
Applicant(s)For all designated states
Statens Serum Institut
Artillerivej 5
2300 Copenhagen S / DK
[2012/50]
Former [2011/35]For all designated states
Statens Serum Institut
Orestads Boulevard 5
2300 Copenhagen S / DK
Former [2011/01]For all designated states
Statens Serum Institut
Artillerivej 5
2300 Copenhagen S / DK
Inventor(s)01 / Theisen, Michael
Hegnsvej 155
2850 Naerum / DK
02 / Olsen, Anja
Jacob Bulls Allé 121
2860 Søborg / DK
03 / Leah, Robert
Henrik Thomsensvej 26
3460 Birkerød / DK
04 / Follmann, Frank
Morkhoj Parkalle 8D
2860 Soborg / DK
05 / Jensen, Klaus
Gyngemose Parkvej 33, 5.th.
2860 Soborg / DK
06 / Andersen, Peter
Sparreholmvej 47
2700 Brønshøj / DK
 [2011/07]
Former [2011/01]01 / Theisen, Michael
N.J. Fjords Allé 20, 4. Th
1957 Frederiksberg C / DK
02 / Olsen, Anja
Jacob Bulls Allé 121
2860 Søborg / DK
03 / Leah, Robert
Henrik Thomsensvej 26
3460 Birkerød / DK
04 / Follmann, Frank
Frejasgade 9, 3.th
2200 Copenhagen N / DK
05 / Jensen, Klaus
Skyttegade 2, 2.tv
2200 Copenhagen N / DK
06 / Andersen, Peter
Sparreholmvej 47
2700 Brønshøj / DK
Representative(s)Plougmann Vingtoft a/s
Strandvejen 70
2900 Hellerup / DK
[N/P]
Former [2011/01]Plougmann & Vingtoft A/S
Sundkrogsgade 9 P.O. Box 831
2100 Copenhagen Ø / DK
Application number, filing date10178623.411.10.2005
[2011/01]
Priority number, dateDK2004000163325.10.2004         Original published format: DK 200401633
DK2005000106919.07.2005         Original published format: DK 200501069
[2011/01]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP2269636
Date:05.01.2011
Language:EN
[2011/01]
Type: A3 Search report 
No.:EP2269636
Date:06.04.2011
[2011/14]
Search report(s)(Supplementary) European search report - dispatched on:EP09.03.2011
ClassificationIPC:A61K39/118, C07K16/12, G01N33/569
[2011/01]
CPC:
C07K14/295 (EP,US); A61K39/118 (EP,US); A61P31/04 (EP);
A61P37/04 (EP)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2011/01]
TitleGerman:Chlamydia trachomatis-Antigene als Impfstoff und zur diagnostischen Verwendung[2011/01]
English:Chlamydia trachomatis antigens for vaccine and diagnostic use[2011/01]
French:Antigènes de Chlamydia trachomatis pour une utilisation en tant que vaccin et pour le diagnostic[2011/01]
Examination procedure06.10.2011Amendment by applicant (claims and/or description)
06.10.2011Examination requested  [2011/46]
01.06.2012Despatch of a communication from the examining division (Time limit: M04)
09.10.2012Reply to a communication from the examining division
05.07.2013Application refused, date of legal effect [2013/51]
05.07.2013Date of oral proceedings
11.07.2013Minutes of oral proceedings despatched
02.08.2013Despatch of communication that the application is refused, reason: substantive examination [2013/51]
Parent application(s)   TooltipEP05790937.6  / EP1812058
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20050790937) is  15.02.2008
Fees paidRenewal fee
23.09.2010Renewal fee patent year 03
23.09.2010Renewal fee patent year 04
23.09.2010Renewal fee patent year 05
23.09.2010Renewal fee patent year 06
24.10.2011Renewal fee patent year 07
15.10.2012Renewal fee patent year 08
15.10.2013Renewal fee patent year 09
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[I]WO9928475  (GENSET SA [FR], et al) [I] 1-16 * page 93, line 31 - page 94, line 20 * * page 47, line 8 - line 18 *;
 [E]WO2006050571  (UNIV QUEENSLAND [AU], et al) [E] 1-16 * page 3, line 31 - page 8, line 31; compound CT561; sequence 20 * * page 24, line 32 - page 26, line 1 * * page 31, line 25 - page 39, line 13 * * page 56, line 4 - line 7 *
 [I]  - "Chlamydia trachomatis secreted protein.", Geneseq, (19991007), Database accession no. AAY37652, URL: EBI, XP002624761 [I] 1-16 * the whole document *
 [A]  - SLEPENKIN ANATOLY ET AL, "Temporal expression of type III secretion genes of Chlamydia pneumoniae.", INFECTION AND IMMUNITY, (200305), vol. 71, no. 5, ISSN 0019-9567, pages 2555 - 2562, XP002624762 [A] 1-16 * the whole document *

DOI:   http://dx.doi.org/10.1128/IAI.71.5.2555-2562.2003
 [A]  - STEPHENS RICHARD S ET AL, "Genome sequence of an obligate intracellular pathogen of humans: Chlamydia trachomatis", SCIENCE (WASHINGTON D C), (19981023), vol. 282, no. 5389, ISSN 0036-8075, pages 754 - 759, XP002624763 [A] 1-16 * page 757, column r, paragraph 2 *

DOI:   http://dx.doi.org/10.1126/science.282.5389.754
    [ ] - "SubName: Full=Yop proteins translocation protein L;", UniProt, (19981101), Database accession no. O84565, URL: EBI [ ] * compound . *
by applicantWO9928475
 WO9927105
 WO9640718
 US4608251
 US4601903
 US4599231
 US4599230
 US4816567
 US6136958
    - ALDERSON, M.R.; BEMENT, T.; DAY, C.H.; ZHU, L.; MOLESH, D.; SLEIKY, Y. A. W.; COLER, R.; LEWINSOHN, D.M.; REED, S.G.; DILLON, D.C., "Wxpression cloning of an immunodominant family of Mycobacterium tuberculosos antigen using human CD4+ T cells", J. EXP. MED., (2000), vol. 191, no. 3, pages 551 - 9
    - ANDERSEN, P.; I. HERON, "Simultaneous electroelution of whole SDS- polyacrylamide gels for the direct cellular analysis of complex protein mixtures", J IMMUNOL METHODS, (1993), vol. 161, no. 1, pages 29 - 39
    - BRANDT, L.; M. ELHAY ET AL., "ESAT-6 subunit vaccination against Mycobacterium tuberculosis", INFECT IMMUN, (2000), vol. 68, no. 2, pages 791 - 5
    - "Human immunity to Chlamydia", BRUNHAM, R. C., Chlamydia Intracellular biology, Pathoqenesis, and Immunity. R. S. Stephens, ASM PRESS, (1999), pages 211 - 238
    - COTE-SIERRA, J.; E. JONGERT ET AL., "A new membrane-bound Oprl lipoprotein expression vector. High production of heterologous fusion proteins in gram (-) bacteria and the implications for oral vaccination", GENE, (1998), vol. 221, no. 1, pages 25 - 34
    - COTTER, T. W.; Q. MENG ET AL., "Protective efficacy of major outer membrane protein-specific immunoglobulin A (IgA) and IgG monoclonal antibodies in a murine model of Chlamydia trachomatis genital tract infection", INFECT.LMMUN., (1995), vol. 63, no. 12, pages 4704 - 4714
    - FLING, S. P.; R. A. SUTHERLAND ET AL., "CD8+ T cells recognize an inclusion membrane-associated protein from the vacuolar pathogen Chlamydia trachomatis", PROC. NATI.ACAD.SCI. U.S.A, (2001), vol. 98, no. 3, pages 1160 - 1165
    - GOODALL, J. C.; G. YEO ET AL., "Identification of Chlamydia trachomatis antigens recognized by human CD4+ T lymphocytes by screening an expression library", EUR.J.LMMUNOL., (2001), vol. 31, no. 5, pages 1513 - 1522
    - GOSSELIN, E. J.; K. WARDWELL ET AL., "Enhanced antigen presentation using human Fc gamma receptor (monocyte/macrophage)-specific immunogens", J IMMUNOL, (1992), vol. 149, no. 11, pages 3477 - 81
    - GRAYSTON, J. T.; S. P. WANG, "The potential for vaccine against infection of the genital tract with Chlamydia trachomatis", SEX TRANSM.DIS., (1978), vol. 5, pages 73 - 77
    - GU, L.; W. M. WENMAN ET AL., "Chlamydia trachomatis RNA polymerase alpha subunit: sequence and structural analysis", J.BACTERIOL., (1995), vol. 177, no. 9, pages 2594 - 2601
    - HARBOE, M.; T. OETTINGER ET AL., "Evidence for occurrence of the ESAT-6 protein in Mycobacterium tuberculosis and virulent Mycobacterium bovis and for its absence in Mycobacterium bovis BCG", INFECT IMMUN, (1996), vol. 64, no. 1, pages 16 - 22
    - HASSELL, A. B.; D. J. REYNOLDS ET AL., "Identification of T-cell stimulatory antigens of Chlamydia trachomatis using synovial fluid-derived T-cell clones", IMMUNOLOGY, (1993), vol. 79, no. 4, pages 513 - 519
    - KATZ, B. P.; B. E. BATTEIGER ET AL., "Effect of prior sexually transmitted disease on the isolation of Chlamydia trachomatis", SEX TRANSM.DIS., (1987), vol. 14, no. 3, pages 160 - 164
    - KILGUS, J.; T. JARDETZKY ET AL., "Analysis of the permissive association of a malaria T cell epitope with DR molecules", J IMMUNOL, (1991), vol. 146, no. 1, pages 307 - 15
    - KUBO, A.; R. S. STEPHENS, "Characterization and functional analysis of PorB, a Chlamydia porin and neutralizing target", MOL.MICROBIOL., (2000), vol. 38, no. 4, pages 772 - 780
    - LAVERDA, D.; L. N. ALBANESE ET AL., "Seroreactivity to Chlamydia trachomatis Hsp10 correlates with severity of human genital tract disease", INFECT.LMMUN., (2000), vol. 68, no. 1, pages 303 - 309
    - MCCAFFERTY, J.; A. D. GRIFFITHS ET AL., "Phage antibodies: filamentous phage displaying antibody variable domains", NATURE, (1990), vol. 348, no. 6301, pages 552 - 4
    - MORRISON, R. P.; H. D. CALDWELL, "Immunity to murine chlamydial genital infection.", INFECT IMMUN, (2002), vol. 70, no. 6, pages 2741 - 51
    - MORRISON, S. G.; H. SU ET AL., "Immunity to murine Chlamydia trachomatis genital tract reinfection involves B cells and CD4(+) T cells but not CD8(+) T cells", LNFECT. LMMUN., (2000), vol. 68, no. 12, pages 6979 - 6987
    - ORTIZ, L.; K. P. DEMICK ET AL., "Chlamydia trachomatis major outer membrane protein (MOMP) epitopes that activate HLA class II-restricted T cells from infected humans", J IMMUNOL, (1996), vol. 157, no. 10, pages 4554 - 67
    - PAL, S.; K. M. BARNHART ET AL., "Vaccination of mice with DNA plasmids coding for the Chlamydia trachomatis major outer membrane protein elicits an immune response but fails to protect against a genital challenge", VACCINE, (1999), vol. 17, no. 5, pages 459 - 465
    - PAL, S.; I. THEODOR ET AL., "Immunization with the Chlamydia trachomatis mouse pneumonitis major outer membrane protein can elicit a protective immune response against a genital challenge", INFECT.LMMUN., (2001), vol. 69, no. 10, pages 6240 - 6247
    - PEARSON, W. R.; D. J. LIPMAN, "Improved tools for biological sequence comparison", PROC NATL ACAD SCI U S A, (1988), vol. 85, no. 8, pages 2444 - 8
    - RAVN, P.; A. DEMISSIE ET AL., "Human T cell responses to the ESAT-6 antigen from Mycobacterium tuberculosis", J INFECT DIS, (1999), vol. 179, no. 3, pages 637 - 45
    - ROLPH, M. S.; I. A. RAMSHAW, "Recombinant viruses as vaccines and immunological tools", CURR OPIN IMMUNOL, (1997), vol. 9, no. 4, pages 517 - 24
    - ROSENKRANDS, I.; E. M. AGGER ET AL., "Cationic liposomes containing mycobacterial lipids: a new powerful Th1 adjuvant system", INFECT IMMUN, (2005), vol. 73, no. 9, pages 5817 - 26
    - SCHACHTER, J.; J. MONCADA ET AL., "Nonculture methods for diagnosing chlamydial infection in patients with trachoma: a clue to the pathogenesis of the disease?", J.LNFECT.DIS., (1988), vol. 158, no. 6, pages 1347 - 1352
    - SHAW, J.; V. GRUND ET AL., "Dendritic cells pulsed with a recombinant chlamydial major outer membrane protein antigen elicit a CD4(+) type 2 rather than type 1 immune response that is not protective", INFECT.LMMUN., (2002), vol. 70, no. 3, pages 1097 - 1105
    - SINIGAGLIA, F.; M. GUTTINGER ET AL., "A malaria T-cell epitope recognized in association with most mouse and human MHC class II molecules", NATURE, (1988), vol. 336, no. 6201, pages 778 - 80
    - STARNBACH, M. N.; W. P. LOOMIS ET AL., "An inclusion membrane protein from Chlamydia trachomatis enters the MHC class I pathway and stimulates a CD8+ T cell response", J IMMUNOL, (2003), vol. 171, no. 9, pages 4742 - 9
    - STEPHENS, R. S.; S. KALMAN ET AL., "Genome sequence of an obligate intracellular pathogen of humans: Chlamydia trachomatis", SCIENCE, (1998), vol. 282, no. 5389, pages 754 - 759
    - STEPHENS, R. S.; E. A. WAGAR ET AL., "High-resolution mapping of serovar-specific and common antigenic determinants of the major outer membrane protein of Chlamydia trachomatis", J.EXP.MED., (1988), vol. 167, no. 3, pages 817 - 831
    - STRYHN, A.; L. O. PEDERSEN ET AL., "Peptide binding specificity of major histocompatibility complex class I resolved into an array of apparently independent subspecificities: quantitation by peptide libraries and improved prediction of binding", EUR J IMMUNOL, (1996), vol. 26, no. 8, pages 1911 - 8
    - SU, H.; H. D. CALDWELL, "CD4+ T cells play a significant role in adoptive immunity to Chlamydia trachomatis infection of the mouse genital tract", INFECT.LMMUN., (1995), vol. 63, no. 9, pages 3302 - 3308
    - SU, H.; M. PARNELL ET AL., "Protective efficacy of a parenterally administered MOMP-derived synthetic oligopeptide vaccine in a murine model of Chlamydia trachomatis genital tract infection: serum neutralizing IgG antibodies do not protect against chlamydial genital tract infection", VACCINE, (1995), vol. 13, no. 11, pages 1023 - 1032
    - THEISEN, M.; S. SOE ET AL., "A Plasmodium falciparum GLURP-MSP3 chimeric protein; expression in Lactococcus lactis, immunogenicity and induction of biologically active antibodies", VACCINE, (2004), vol. 22, no. 9-10, pages 1188 - 98
    - TIPPLES, G.; G. MCCLARTY, "Cloning and expression of the Chlamydia trachomatis gene for CTP synthetase", J.BIOI.CHEM., (1995), vol. 270, no. 14, pages 7908 - 7914
    - ULMER, J. B.; J. J. DONNELLY ET AL., "Heterologous protection against influenza by injection of DNA encoding a viral protein", SCIENCE, (1993), vol. 259, no. 5102, pages 1745 - 9
    - WANG, S. P.; J. T. GRAYSTON ET AL., "Trachoma vaccine studies in monkeys", AM.J.OPHTHALMOL., (1967), vol. 63, no. 5, page 30
    - ZHANG, D. J.; X. YANG ET AL., "Characterization of immune responses following intramuscular DNA immunization with the MOMP gene of Chlamydia trachomatis mouse pneumonitis strain", IMMUNOLOGY, (1999), vol. 96, no. 2, pages 314 - 321
    - ZHANG, Y.; J. TAO ET AL., "Elongation factor Ts of Chlamydia trachomatis: structure of the gene and properties of the protein", ARCH.BIOCHEM.BIOPHYS., (1997), vol. 344, no. 1, pages 43 - 52
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.